AstraZeneca Aims to Make Cell Therapy More Accessible With $425M EsoBiotec Acquisition
AstraZeneca already has cell therapies in its pipeline, and it is now expanding its scope further with a deal to ...
AstraZeneca already has cell therapies in its pipeline, and it is now expanding its scope further with a deal to ...
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston. In ...
MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to ...
Roche is expanding its scope to a promising but competitive new obesity target, committing $1.65 billion up front to partner ...
Protein therapies for the eye must be dosed as frequent injections. Gene therapy offers one-time treatment, but must also be ...
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the ...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children, ...
The device in the lab at TU Wien. Credit: Vienna University of Technology Some health problems, including chronic pain, inflammation ...
Researchers from Tokyo Metropolitan University have developed a new dye that can strongly absorb second near-IR radiation and transform it ...
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.